Mini Review
Published on 22 Jan 2021
Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.595547
- 22,019 views
- 33 citations
Type at least 3 characters
1,082 articles
Articles
Original Research
Published on 21 Jan 2021
Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.629183
- 6,087 views
- 28 citations
Mini Review
Published on 21 Jan 2021
Autoimmune Encephalitis in Latin America: A Critical Review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.606350
- 6,575 views
- 14 citations
Original Research
Published on 21 Jan 2021
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.612304
- 5,363 views
- 12 citations
Mini Review
Published on 21 Jan 2021
Should We Use Clinical Tools to Identify Disease Progression?
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.628542
- 6,063 views
- 21 citations
Case Report
Published on 15 Jan 2021
Case Report: Anti-LGI1 Limbic Encephalitis Associated With Anti-thyroid Autoantibodies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.620483
- 8,153 views
- 7 citations
Original Research
Published on 15 Jan 2021
Remedial Effect of Intravenous Cyclophosphamide in Corticosteroid-Refractory Patients in the Acute Phase of Neuromyelitis Optica Spectrum Disorder-Related Optic Neuritis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.612097
- 3,986 views
- 7 citations
Original Research
Published on 15 Jan 2021
Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.592304
- 8,011 views
- 17 citations
Original Research
Published on 14 Jan 2021
Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.621010
- 4,820 views
- 14 citations
Case Report
Published on 13 Jan 2021
Case Report: Microglia Composition and Immune Response in an Immunocompetent Patient With an Intracranial Syphilitic Gumma
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.615434
- 1,982 views
- 4 citations
Editorial
Published on 12 Jan 2021
Editorial: Corticospinal Excitability in Patients With Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.635612
- 1,864 views
- 7 citations
Original Research
Published on 12 Jan 2021
Brain Magnetic Resonance Imaging Characteristics of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis and Their Clinical Relevance: A Single-Center Study in China
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.618109
- 7,054 views
- 17 citations
Original Research
Published on 12 Jan 2021
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.593527
- 3,187 views
- 4 citations
Case Report
Published on 11 Jan 2021
Case Report: Novel Arylsulfatase A (ARSA) Gene Mutations in a Patient With Adult-Onset Metachromatic Leukodystrophy Misdiagnosed as Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.576881
- 4,309 views
- 3 citations
Case Report
Published on 06 Jan 2021
Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.591395
- 2,530 views
- 6 citations
Original Research
Published on 29 Dec 2020
The Association Between Age and Prognosis in Patients Under 45 Years of Age With Anti-NMDA Receptor Encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2020.612632
- 2,743 views
- 6 citations